Kidney transplantation is the ideal choice of kidney replacement therapy in children as it
offers a low risk of mortality and a better quality of life. A wide variance in the access to …

Health claims databases offer opportunities for studies on large populations of patients with
kidney disease and health outcomes in a non-experimental setting. Among others, their …

Introduced in 1995, mycophenolate mofetil (MMF) would become the most powerful
antiproliferative agent in the field of organ transplantation, thereby supplanting azathioprine …

Patients undergoing organ transplantation transition from one life-altering issue (organ
dysfunction) to a lifelong commitment—immunosuppression. Regimens of …

Aims: To assess stakeholder perspectives regarding the clinical utility of pharmacogenomic
(PGx) testing following kidney, liver, and heart transplantation. Methods: We conducted …

Background Kidney transplant recipients must take immunosuppressant drugs to prevent
rejection and maintain transplant function. Medicare coverage of immunosuppressant drugs …

Purpose This study evaluates the use, benefit-risk profile, and economic impact of generic
immunosuppressants (tacrolimus-TAC, cyclosporine-CsA, and mycophenolate-MYC) in …

Solid organ transplantation (SOT) is the best treatment option for end-stage organ disease.
The number of SOT procedures has been steadily increasing worldwide during the past …

Viral infections have been considered as a major cause of morbidity and mortality after
kidney transplantation in pediatric cohort. Children are at high risk of acquiring virus-related …

Introduction Heart transplantation in children is associated with high resource utilization.
However, the financial burden on families and the association with patient and demographic …